AI Summary
This is a limited competition grant opportunity (PAR-25-156) from HHS-NIH11 for High Impact Specialized Innovation Programs in Clinical and Translational Science. The grant, CFDA 93.350, allows for optional clinical trials (RC2 Clinical Trials Optional).